VAISHALI — Vaishali Pharma Cashflow Statement
0.000.00%
- IN₹1.43bn
- IN₹1.27bn
- IN₹862.80m
- 49
- 47
- 29
- 35
Annual cashflow statement for Vaishali Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.791 | 14 | 57.3 | 88.5 | 9.26 |
Depreciation | |||||
Non-Cash Items | 53.4 | 30.2 | 11.1 | 6.56 | 53.5 |
Other Non-Cash Items | |||||
Changes in Working Capital | -26.4 | -28.4 | -59.8 | -89.3 | -59.7 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 32.2 | 20.1 | 13.2 | 10.8 | 8.07 |
Capital Expenditures | -0.526 | -1.26 | -8.65 | -2.97 | -1.11 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.333 | 0.157 | 0.18 | 5.79 | 13.1 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.193 | -1.1 | -8.47 | 2.82 | 12 |
Financing Cash Flow Items | -25.3 | -26.2 | -25.4 | -19.8 | -17.4 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -31.4 | -18.1 | 4.17 | -17.3 | -14.2 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.606 | 0.892 | 8.89 | -3.71 | 5.93 |